Amalgamated Bank Amphastar Pharmaceuticals, Inc. Transaction History
Amalgamated Bank
- $11.7 Billion
- Q1 2025
A detailed history of Amalgamated Bank transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 10,761 shares of AMPH stock, worth $279,893. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,761
Previous 10,998
2.15%
Holding current value
$279,893
Previous $408,000
23.53%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$63 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$57.5 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$41.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$35.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.27B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...